Cargando…
Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease
Advanced liver diseases account for approximately 2 million deaths annually worldwide. Roughly, half of liver disease-associated deaths arise from complications of cirrhosis and the other half driven by viral hepatitis and hepatocellular carcinoma. Unfortunately, the development of therapeutic strat...
Autores principales: | Varadharajan, Venkateshwari, Massey, William J., Brown, J. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240865/ https://www.ncbi.nlm.nih.gov/pubmed/35636492 http://dx.doi.org/10.1016/j.jlr.2022.100234 |
Ejemplares similares
-
MBOAT7-driven phosphatidylinositol remodeling promotes the progression of clear cell renal carcinoma
por: Neumann, Chase K.A., et al.
Publicado: (2020) -
Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease
por: Helsley, Robert N, et al.
Publicado: (2019) -
Functional and Structural Changes in the Membrane-Bound O-Acyltransferase Family Member 7 (MBOAT7) Protein: The Pathomechanism of a Novel MBOAT7 Variant in Patients With Intellectual Disability
por: Lee, Jiwon, et al.
Publicado: (2022) -
MBOAT7-driven lysophosphatidylinositol acylation in adipocytes contributes to systemic glucose homeostasis
por: Massey, William J., et al.
Publicado: (2023) -
The structure of phosphatidylinositol remodeling MBOAT7 reveals its catalytic mechanism and enables inhibitor identification
por: Wang, Kun, et al.
Publicado: (2023)